• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于心脏磁共振成像的心力衰竭患者危及生命的室性快速性心律失常风险分层:SNE评分

A Cardiac Magnetic Resonance-Based Risk Stratification for Life-Threatening Ventricular Tachyarrhythmias in Heart Failure: The SNE Score.

作者信息

Xing Xing, Li Xiaofei, Fan Xiaohan, Liu Xiaoqiang, Zhang Yi, Zhang Lei, Yao Yan, Wang Fang

机构信息

Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

NMR Biomed. 2025 Sep;38(9):e70098. doi: 10.1002/nbm.70098.

DOI:10.1002/nbm.70098
PMID:40754468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12318897/
Abstract

Risk stratification for sudden cardiac death (SCD) mainly relies on severely reduced left ventricular ejection fraction (LVEF), but its poor predictive efficacy fails to meet clinical needs. Myocardial scarring identified using cardiac magnetic resonance (CMR) imaging has emerged as a potent risk indicator for SCD and life-threatening ventricular tachyarrhythmias (LTVTA). This study aimed to develop a risk prediction score for SCD and ventricular tachyarrhythmias in symptomatic heart failure. Consecutive patients with nonischemic heart failure undergoing CMR were monitored from 2018 to 2024. A risk stratification score was developed by integrating CMR parameters with clinical variables. Among the 199 patients, the median LVEF was 32.7%, and the average age was 50.3 ± 15.2 years. During a median observation period of 3 years, 21 (10.5%) patients experienced LTVTA. Among multiple CMR parameters, the presence of late gadolinium enhancement (LGE) was the only independent risk factor for LTVTA. The final risk scoring model comprised the presence of LGE (hazard ratio, 10.68; p = 0.023), assigned a score of 2; syncope (hazard ratio, 4.41; p = 0.003), assigned a score of 1; and nonsustained ventricular tachycardia (hazard ratio, 3.82; p = 0.004), assigned a score of 1. A total score of ≥ 3 was considered high risk. Harrell's C-statistic was 0.814 in the derivation cohort and 0.785 in the external validation cohort. The 3-year cumulative risks for the low- and high-risk groups were 3.6% and 32.8%, respectively. Among CMR parameters, the presence of LGE was identified as the sole independent and strong risk marker of LTVTA. The novel scoring model may assist in the preliminary screening of patients with symptomatic heart failure with a potentially elevated risk.

摘要

心脏性猝死(SCD)的风险分层主要依赖于严重降低的左心室射血分数(LVEF),但其预测效果不佳,无法满足临床需求。利用心脏磁共振(CMR)成像识别的心肌瘢痕已成为SCD和危及生命的室性快速心律失常(LTVTA)的有力风险指标。本研究旨在为有症状心力衰竭患者的SCD和室性快速心律失常制定风险预测评分。对2018年至2024年接受CMR检查的连续性非缺血性心力衰竭患者进行监测。通过将CMR参数与临床变量相结合,制定了一个风险分层评分。在199例患者中,LVEF中位数为32.7%,平均年龄为50.3±15.2岁。在中位观察期3年期间,21例(10.5%)患者发生LTVTA。在多个CMR参数中,钆延迟强化(LGE)的存在是LTVTA的唯一独立危险因素。最终的风险评分模型包括LGE的存在(风险比,10.68;p = 0.023),评分为2分;晕厥(风险比,4.41;p = 0.003),评分为1分;非持续性室性心动过速(风险比,3.82;p = 0.004),评分为1分。总分≥3分被认为是高风险。在推导队列中,Harrell's C统计量为0.814,在外部验证队列中为0.785。低风险组和高风险组的3年累积风险分别为3.6%和32.8%。在CMR参数中,LGE的存在被确定为LTVTA唯一独立且强大的风险标志物。该新型评分模型可能有助于对有症状心力衰竭且潜在风险升高的患者进行初步筛查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fa/12318897/bf2494291aa1/NBM-38-e70098-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fa/12318897/ddc76ae650cf/NBM-38-e70098-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fa/12318897/0ff36184dedb/NBM-38-e70098-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fa/12318897/3f40fa217dda/NBM-38-e70098-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fa/12318897/9151497c2863/NBM-38-e70098-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fa/12318897/11e9834aa869/NBM-38-e70098-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fa/12318897/bf2494291aa1/NBM-38-e70098-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fa/12318897/ddc76ae650cf/NBM-38-e70098-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fa/12318897/0ff36184dedb/NBM-38-e70098-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fa/12318897/3f40fa217dda/NBM-38-e70098-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fa/12318897/9151497c2863/NBM-38-e70098-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fa/12318897/11e9834aa869/NBM-38-e70098-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fa/12318897/bf2494291aa1/NBM-38-e70098-g001.jpg

相似文献

1
A Cardiac Magnetic Resonance-Based Risk Stratification for Life-Threatening Ventricular Tachyarrhythmias in Heart Failure: The SNE Score.基于心脏磁共振成像的心力衰竭患者危及生命的室性快速性心律失常风险分层:SNE评分
NMR Biomed. 2025 Sep;38(9):e70098. doi: 10.1002/nbm.70098.
2
Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis.心脏磁共振钆延迟增强预测非缺血性心肌病不良心血管结局:系统评价和荟萃分析。
Circ Cardiovasc Imaging. 2014 Mar;7(2):250-258. doi: 10.1161/CIRCIMAGING.113.001144. Epub 2013 Dec 20.
3
[The predictive value of cardiac MRI for the first episode of malignant ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy].[心脏磁共振成像对致心律失常性右室心肌病首次恶性室性心律失常发作的预测价值]
Zhonghua Xin Xue Guan Bing Za Zhi. 2025 Jul 24;53(7):784-791. doi: 10.3760/cma.j.cn112148-20250117-00055.
4
Magnetic resonance imaging quantification of left ventricular mechanical dispersion and scar heterogeneity optimize risk stratification after myocardial infarction.磁共振成像对左心室机械离散度和瘢痕异质性的量化可优化心肌梗死后的风险分层。
BMC Cardiovasc Disord. 2025 Jan 4;25(1):2. doi: 10.1186/s12872-024-04451-4.
5
Myocardial MRI Cine Radiomics: A Novel Approach to Risk-Stratification for Major Adverse Cardiovascular Events in Patients With ST-Elevation Myocardial Infarction.心肌MRI电影放射组学:ST段抬高型心肌梗死患者主要不良心血管事件风险分层的新方法。
J Magn Reson Imaging. 2025 Feb 11. doi: 10.1002/jmri.29739.
6
Comprehensive Phenotypic Characterization of Late Gadolinium Enhancement Predicts Sudden Cardiac Death in Coronary Artery Disease.全面表型特征分析预测冠状动脉疾病患者的心脏性猝死。
JACC Cardiovasc Imaging. 2023 May;16(5):628-638. doi: 10.1016/j.jcmg.2022.10.020. Epub 2023 Jan 11.
7
Incremental Prognostic Value of Hippocampal Metabolic Activity for Sudden Cardiac Death in Patients With Heart Failure With Reduced Ejection Fraction.射血分数降低的心力衰竭患者海马代谢活性对心源性猝死的增量预后价值。
J Am Heart Assoc. 2025 Jul;14(13):e039147. doi: 10.1161/JAHA.124.039147. Epub 2025 Jun 18.
8
Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis.晚期钆增强与扩张型心肌病中心律失常或猝死风险:系统评价和荟萃分析。
JACC Heart Fail. 2017 Jan;5(1):28-38. doi: 10.1016/j.jchf.2016.09.017. Epub 2016 Dec 21.
9
The incremental role of late gadolinium enhancement in risk stratifying high risk patients with hypertrophic cardiomyopathy.延迟钆增强在肥厚型心肌病高危患者风险分层中的增量作用。
Am Heart J. 2025 Nov;289:28-37. doi: 10.1016/j.ahj.2025.04.030. Epub 2025 May 3.
10
Cardiac resynchronization therapy risk stratified by magnetic resonance imaging and optimized by left bundle branch pacing: Results from long-term follow-up of MADURAI LBBP study.通过磁共振成像进行风险分层并经左束支起搏优化的心脏再同步治疗:马杜赖左束支起搏研究的长期随访结果
Heart Rhythm. 2025 Aug;22(8):2018-2027. doi: 10.1016/j.hrthm.2025.04.040. Epub 2025 Apr 26.

本文引用的文献

1
The Lancet Commission to reduce the global burden of sudden cardiac death: a call for multidisciplinary action.柳叶刀委员会减少全球心源性猝死负担:呼吁采取多学科行动。
Lancet. 2023 Sep 9;402(10405):883-936. doi: 10.1016/S0140-6736(23)00875-9. Epub 2023 Aug 27.
2
Implantable Cardioverter-Defibrillator for Primary Prevention in Asia.亚洲用于一级预防的植入式心脏复律除颤器
JACC Asia. 2023 Mar 7;3(3):321-334. doi: 10.1016/j.jacasi.2022.11.014. eCollection 2023 Jun.
3
Cardiac Magnetic Resonance in the Evaluation of Patients With Frequent Premature Ventricular Complexes.
心脏磁共振在频繁室性早搏患者评估中的应用。
JACC Clin Electrophysiol. 2022 Sep;8(9):1122-1132. doi: 10.1016/j.jacep.2022.06.021. Epub 2022 Aug 31.
4
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.2022年欧洲心脏病学会室性心律失常患者管理和心脏性猝死预防指南
Eur Heart J. 2022 Oct 21;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262.
5
Myocardial Fibrosis Predicts Ventricular Arrhythmias and Sudden Death After Cardiac Electronic Device Implantation.心肌纤维化可预测心脏电子设备植入后室性心律失常和猝死。
J Am Coll Cardiol. 2022 Feb 22;79(7):665-678. doi: 10.1016/j.jacc.2021.11.050.
6
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
7
Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients With Nonischemic Dilated Cardiomyopathy.非缺血性扩张型心肌病患者室性心律失常和猝死的风险分层改善。
J Am Coll Cardiol. 2021 Jun 15;77(23):2890-2905. doi: 10.1016/j.jacc.2021.04.030.
8
Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death.预测植入式心脏复律除颤器在心脏性猝死一级预防中疗效的预测模型的开发与外部验证
Europace. 2021 Jun 7;23(6):887-897. doi: 10.1093/europace/euab012.
9
Relationship of LVEF and Myocardial Scar to Long-Term Mortality Risk and Mode of Death in Patients With Nonischemic Cardiomyopathy.非缺血性心肌病患者左心室射血分数和心肌瘢痕与长期死亡风险及死亡方式的关系
Circulation. 2021 Apr 6;143(14):1343-1358. doi: 10.1161/CIRCULATIONAHA.120.048477. Epub 2021 Jan 22.
10
Myocardial Fibrosis as a Predictor of Sudden Death in Patients With Coronary Artery Disease.心肌纤维化作为冠心病患者猝死的预测因子。
J Am Coll Cardiol. 2021 Jan 5;77(1):29-41. doi: 10.1016/j.jacc.2020.10.046.